Triple Strength, Highly Bioavailable Curcumin
TherActive Triple is an advanced curcumin product that is concentrated to contain 180mg of curcumin per capsule, with one capsule being bioequivalent to 4860mg of regular curcumin.
Theracurmin has been clinically trialled to increase plasma curcumin levels in a dose-dependent manner.

• Highly bioavailable curcumin.
• May help down-regulate inflammatory mediators.
• May help reduce joint inflammation associated with arthritis.
• Antioxidant support.
• May help protect LDL cholesterol from oxidation.
• May help maintain healthy digestive function and emulsify fats in the digestive tract.
• May support normal gallbladder contraction.
• In vitro evidence suggests curcumin may support liver function by up-regulating phase 2 detoxification enzymes.
• In vitro evidence suggests curcumin may support the repair of DNA damaged by oxidative stress.
• Vegan and vegetarian friendly

Ingredient	Per 1 cap
Theracurmin	600 mg
equiv. Curcumin	180 mg

No added dairy, gluten, shellfish, soy protein, yeast.
Vegan & vegetarian friendly.
Contains maltose.

Adults: Take 1 capsule daily or as directed by your healthcare practitioner.
Oral doses of Theracurmin has been used in humans at levels up to 4000mg.

If symptoms persist consult your healthcare practitioner.
Vitamin supplements should not replace a balanced diet.
Contains maltose.
Always read the label. Use only as directed.

Prescribing Information:
This product is not recommended for use in pregnancy or lactation.
The safety of oral doses of Theracurmin has been demonstrated in humans at levels up to 4000mg.
Curcumin lacks any major side effects.
Turmeric can cause gallbladder contractions and should not be used by individuals with gallstones or bile duct obstruction.
Turmeric has an antiplatelet effect and may cause excessive bleeding if used perioperatively. Advise patients to discontinue use at least two weeks before elective surgery.
Turmeric has an antiplatelet effect; avoid concomitant use with anticoagulant/antiplatelet drugs
Animal studies suggest curcumin may reduce the efficacy of cyclophosphamide.